These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15618965)

  • 1. Role of B-cell antigen receptor-associated molecules and lipid rafts in CD5-induced apoptosis of B CLL cells.
    Renaudineau Y; Nédellec S; Berthou C; Lydyard PM; Youinou P; Pers JO
    Leukemia; 2005 Feb; 19(2):223-9. PubMed ID: 15618965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia.
    Pers JO; Berthou C; Porakishvili N; Burdjanadze M; Le Calvez G; Abgrall JF; Lydyard PM; Youinou P; Jamin C
    Leukemia; 2002 Jan; 16(1):44-52. PubMed ID: 11840262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line.
    Minuzzo S; Indraccolo S; Tosello V; Piovan E; Cabrelle A; Trentin L; Semenzato G; Amadori A
    Br J Haematol; 2005 Sep; 130(6):878-89. PubMed ID: 16156858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis induction by hypercross-linking of the surface antigen CD5 with anti-CD5 monoclonal antibodies in B cell chronic lymphocytic leukemia.
    Cioca DP; Kitano K
    Leukemia; 2002 Mar; 16(3):335-43. PubMed ID: 11896536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia.
    Allsup DJ; Kamiguti AS; Lin K; Sherrington PD; Matrai Z; Slupsky JR; Cawley JC; Zuzel M
    Cancer Res; 2005 Aug; 65(16):7328-37. PubMed ID: 16103084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70.
    Gladkikh AA; Potashnikova DM; Tatarskiy V; Yastrebova M; Khamidullina A; Barteneva N; Vorobjev I
    Cancer Med; 2017 Dec; 6(12):2984-2997. PubMed ID: 29125235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
    Cabezudo E; Carrara P; Morilla R; Matutes E
    Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD5 provides viability signals to B cells from a subset of B-CLL patients by a mechanism that involves PKC.
    Perez-Chacon G; Vargas JA; Jorda J; Morado M; Rosado S; Martin-Donaire T; Losada-Fernandez I; Rebolleda N; Perez-Aciego P
    Leuk Res; 2007 Feb; 31(2):183-93. PubMed ID: 16725198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant B cell receptor signaling from B29 (Igbeta, CD79b) gene mutations of chronic lymphocytic leukemia B cells.
    Gordon MS; Kato RM; Lansigan F; Thompson AA; Wall R; Rawlings DJ
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5504-9. PubMed ID: 10792036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemia-associated changes identified by quantitative flow cytometry. II. CD5 over-expression and monitoring in B-CLL.
    Lavabre-Bertrand T; Janossy G; Exbrayat C; Bourquard P; Duperray C; Navarro M
    Leukemia; 1994 Sep; 8(9):1557-63. PubMed ID: 7522294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells.
    Tibaldi E; Brunati AM; Zonta F; Frezzato F; Gattazzo C; Zambello R; Gringeri E; Semenzato G; Pagano MA; Trentin L
    Leukemia; 2011 Nov; 25(11):1768-81. PubMed ID: 21701493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell response to surface IgM cross-linking identifies different prognostic groups of B-chronic lymphocytic leukemia patients.
    Nédellec S; Renaudineau Y; Bordron A; Berthou C; Porakishvili N; Lydyard PM; Pers JO; Youinou P
    J Immunol; 2005 Mar; 174(6):3749-56. PubMed ID: 15749915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia.
    Alfarano A; Indraccolo S; Circosta P; Minuzzo S; Vallario A; Zamarchi R; Fregonese A; Calderazzo F; Faldella A; Aragno M; Camaschella C; Amadori A; Caligaris-Cappio F
    Blood; 1999 Apr; 93(7):2327-35. PubMed ID: 10090943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From normal to clonal B cells: Chronic lymphocytic leukemia (CLL) at the crossroad between neoplasia and autoimmunity.
    Ghia P; Scielzo C; Frenquelli M; Muzio M; Caligaris-Cappio F
    Autoimmun Rev; 2007 Dec; 7(2):127-31. PubMed ID: 18035322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetrical phosphorylation and function of immunoreceptor tyrosine-based activation motif tyrosines in B cell antigen receptor signal transduction.
    Pao LI; Famiglietti SJ; Cambier JC
    J Immunol; 1998 Apr; 160(7):3305-14. PubMed ID: 9531288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD5-positive B cells at the crossroads of B cell malignancy and nonorgan-specific autoimmunity.
    Youinou P; Pers JO; Jamin C; Lydyard PM
    Pathol Biol (Paris); 2000 Jul; 48(6):574-6. PubMed ID: 10965537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cells.
    Lankester AC; van Schijndel GM; van der Schoot CE; van Oers MH; van Noesel CJ; van Lier RA
    Blood; 1995 Aug; 86(3):1090-7. PubMed ID: 7620163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD79a detected by ZL7.4 separates chronic lymphocytic leukemia from mantle cell lymphoma in the leukemic phase.
    Bell PB; Rooney N; Bosanquet AG
    Cytometry; 1999 Jun; 38(3):102-5. PubMed ID: 10397328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages.
    Eksioğlu-Demiralp E; Alpdoğan O; Aktan M; Firatli T; Oztürk A; Budak T; Bayik M; Akoğlu T
    Leukemia; 1996 Aug; 10(8):1331-9. PubMed ID: 8709639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD5 is dissociated from the B-cell receptor in B cells from bovine leukemia virus-infected, persistently lymphocytotic cattle: consequences to B-cell receptor-mediated apoptosis.
    Cantor GH; Pritchard SM; Dequiedt F; Willems L; Kettmann R; Davis WC
    J Virol; 2001 Feb; 75(4):1689-96. PubMed ID: 11160667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.